These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1478067)

  • 1. Heparin-binding properties of lactoferrin and lysozyme.
    Zou S; Magura CE; Hurley WL
    Comp Biochem Physiol B; 1992 Dec; 103(4):889-95. PubMed ID: 1478067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.
    van Berkel PH; Geerts ME; van Veen HA; Mericskay M; de Boer HA; Nuijens JH
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):145-51. PubMed ID: 9359845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the ceruloplasmin-lactoferrin complex.
    Pulina MO; Zakharova ET; Sokolov AV; Shavlovski MM; Bass MG; Solovyov KV; Kokryakov VN; Vasilyev VB
    Biochem Cell Biol; 2002; 80(1):35-9. PubMed ID: 11908641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactions of denatured proteins with other cellular components to form insoluble aggregates and protection by lactoferrin.
    Takase K
    FEBS Lett; 1998 Dec; 441(2):271-4. PubMed ID: 9883898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of hyaluronan to lysozyme at various pHs and salt concentrations.
    Van Damme MP; Moss JM; Murphy WH; Preston BN
    Biochem Int; 1991 Jul; 24(4):605-13. PubMed ID: 1799364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of oligonucleotides with barrier fluid proteins.
    Laktionov PP; Rykova EYu ; Krepkii DV; Bryksin AV; Vlassov VV
    Biochemistry (Mosc); 1997 Jun; 62(6):613-8. PubMed ID: 9284542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin binding to lysozyme-treated Micrococcus luteus.
    Perraudin JP; Prieels JP
    Biochim Biophys Acta; 1982 Sep; 718(1):42-8. PubMed ID: 7138905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis.
    Venge P; Hällgren R; Stålenheim G; Olsson I
    Scand J Haematol; 1979 Apr; 22(4):317-26. PubMed ID: 224447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif.
    Li YM; Tan AX; Vlassara H
    Nat Med; 1995 Oct; 1(10):1057-61. PubMed ID: 7489363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility and binding properties of PEGylated lysozyme derivatives with increasing molecular weight on hydrophobic-interaction chromatographic resins.
    Müller E; Josic D; Schröder T; Moosmann A
    J Chromatogr A; 2010 Jul; 1217(28):4696-703. PubMed ID: 20570270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes.
    Radi R; Rubbo H; Bush K; Freeman BA
    Arch Biochem Biophys; 1997 Mar; 339(1):125-35. PubMed ID: 9056242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme.
    Leitch EC; Willcox MDP
    J Med Microbiol; 1999 Sep; 48(9):867-871. PubMed ID: 10482299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein composition of different sized casein micelles in milk after the binding of lactoferrin or lysozyme.
    Anema SG; de Kruif CG
    J Agric Food Chem; 2013 Jul; 61(29):7142-9. PubMed ID: 23808832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism and substitution in the lactoferrins.
    Brodie AM; Ainscough EW; Baker EN; Baker HM; Shongwe MS; Smith CA
    Adv Exp Med Biol; 1994; 357():33-44. PubMed ID: 7762444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex coacervation of lysozyme and heparin: complex characterization and protein stability.
    van de Weert M; Andersen MB; Frokjaer S
    Pharm Res; 2004 Dec; 21(12):2354-9. PubMed ID: 15648269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of heparin-binding to lactoferrin from human milk and from human granulocytes by means of affinity capillary electrophoresis.
    Heegaard NH; Brimnes J
    Electrophoresis; 1996 Dec; 17(12):1916-20. PubMed ID: 9034775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microcalorimetric study of the adsorption of lactoferrin in supermacroporous continuous cryogel with immobilized Cu(2+) ions.
    Carvalho BM; Da Silva LH; Carvalho LM; Soares AM; Minim LA; Da Silva SL
    J Chromatogr A; 2013 Oct; 1312():1-9. PubMed ID: 24034975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of tear lipocalin with lysozyme and lactoferrin.
    Gasymov OK; Abduragimov AR; Yusifov TN; Glasgow BJ
    Biochem Biophys Res Commun; 1999 Nov; 265(2):322-5. PubMed ID: 10558865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption behaviour and surfactant elution of cationic salivary proteins at solid/liquid interfaces, studied by in situ ellipsometry.
    Svendsen IE; Lindh L; Arnebrant T
    Colloids Surf B Biointerfaces; 2006 Dec; 53(2):157-66. PubMed ID: 17029761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of heparin to human high molecular weight kininogen.
    Björk I; Olson ST; Sheffer RG; Shore JD
    Biochemistry; 1989 Feb; 28(3):1213-21. PubMed ID: 2713360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.